News - Bonvadis®

News & Insights

•2026-02-22•News
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia.
According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, 11th Edition, in Colombia, approximately 3.0 million adults currently live with diabetes, representing a prevalence rate of 8.4%, with projections indicating the number will climb to 4.3 million by 2050. Market data further show that Colombia’s advanced wound care (AWC) markets are growing steadily. In Colombia, the AWC market was valued at approximately USD 61.7 million in 2023 and is projected to reach USD 92.4 million by 2030, with a CAGR of 5.9%.
Read More
•2026-01-31•News
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia.
According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, 11th Edition, in Colombia, approximately 3.0 million adults currently live with diabetes, representing a prevalence rate of 8.4%, with projections indicating the number will climb to 4.3 million by 2050. Market data further show that Colombia’s advanced wound care (AWC) markets are growing steadily. In Colombia, the AWC market was valued at approximately USD 61.7 million in 2023 and is projected to reach USD 92.4 million by 2030, with a CAGR of 5.9%.
Read More
•2026-01-05•News
Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by EDA Egypt.
With a population of approximately 108 million and a diabetic population of approximately 11 million, Egypt's wound care market has great potential.
Read More
•2025-12-19•News
Bonvadis® topical cream received medical device import license for all indications in wounds for India.
According to Invest India, the country’s medical device market is valued at approximately USD 11 billion and is one of the fastest-growing among emerging markets. With a projected 15% CAGR (2.5 times the global average) the market is expected to reach USD 50 billion by 2030.
Read More
•2025-11-11•News
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Health Canada.
According to the forecast report of Data Bridge Market Research, the North America is the largest market of global advanced wound care market. The CAGR is 6.4% in the forecast period from 2020 to 2027, and it is expected to reach 4.6 billion dollars by 2027.
Read More
•2025-10-27•News
The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Argentina National Administration of Drugs, Foods, and Medical Devices (ANMAT).
In Argentina, there are an estimated 4.3 million adults living with diabetes, the second-highest figure in South America, projected to rise to 5.9 million by 2050. Currently, among diabetic foot ulcer (DFU) patients, the major amputation rate is 8.3% and the mortality rate is 4.49%, highlighting the urgent need for effective treatment options. Argentina’s advanced wound care (AWC) market was valued at approximately USD 96.7 million in 2023 and is expected to reach USD 143.6 million by 2030, with a compound annual growth rate (CAGR) of 5.8%.
Read More

Events

2026-01-15San Francisco, USA

Oneness Biotech Highlights Global Strategy at J.P. Morgan Healthcare Conference

Oneness Biotech presented today at the J.P. Morgan Healthcare Conference, one of the world’s most influential healthcare investment events. President Dr. Shuling Cheng outlined the company’s global strategy and growth platform, emphasizing Oneness’ commitment to building a leading metabolic disease company. A key focus of the presentation was Bonvadis® (ON101) and its role in redefining wound care and limb preservation.

2025-09-12Italy, Pisa

Oneness Biotech to participate in the 16th International Diabetic Foot Course 2025

Oneness Biotech is excited to join the 16th International Diabetic Foot Course (Oct 1–4, 2025, Hotel San Ranieri, Pisa, Italy), a premier global platform where clinicians, researchers, and industry leaders come together with a shared mission: advancing DFU care and improving patient outcomes.

2025-09-05Las Vegas, USA

Expert Talk Recap: Dr. Brock Liden, DPM on Transforming Outcomes in VLU & Chronic Wounds

Dr. Brock Liden, an internationally recognized podiatrist with more than 25 years of experience in chronic wound management, delivered one of the most engaging sessions at SAWC Fall 2025. His presentation explored how consistent wound-bed management and supportive topical therapy can help drive wound progression in both diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

2025-09-05Las Vegas, USA

Expert Talk Recap: Dr. Chia-Ding Shih, DPM, MPH on Achieving Complete Healing in Challenging Infected DFUs

Dr. Shih highlighted a harsh reality: elderly DFU patients face higher rates of non-healing, infection, and major amputation compared with younger populations, due largely to PAD, long-standing diabetes, and impaired perfusion . Despite careful offloading and SOC, many wounds stagnate unless inflammation is addressed directly.

2025-09-02Las Vegas, USA

Expert Talks – Meet with Chia-Ding Shih, DPM, on September 5th at 1:00 PM at SAWC Fall 2025

Meet Dr. Shih: Board-certified podiatric surgeon in chronic wounds of the foot and ankle. Published researcher in diabetic foot care and amputation prevention. Mentor and thought leader in podiatric medicine and limb preservation

2025-09-02Las Vegas, USA

Expert Talk Recap: Dr. Daniel L. Kapp, MD on Fast Healing Solution for Post-Surgical Wounds

At SAWC Fall 2025, Dr. Daniel L. Kapp, board-certified plastic surgeon and nationally recognized authority in wound reconstruction and biologic therapies, led an insightful session on the growing clinical burden of non-healing post-surgical wounds and the emerging strategies for supporting faster, more predictable recovery.

2025-09-02Las Vegas, USA

Oneness Biotech to Exhibit at the Symposium on Advanced Wound Care (SAWC) Fall 2025

Oneness Biotech Co., Ltd. is proud to announce its participation in the Symposium on Advanced Wound Care (SAWC) Fall 2025, taking place in the United States. As one of the leading events in the field of wound care, SAWC Fall attracts thousands of clinicians, researchers, and industry professionals from around the world.

2025-05-04Grapevine, Texas, USA

Oneness Biotech Participated in SAWC | WHS Spring meeting on April 30-May 4, 2025

The Symposium on Advanced Wound Care (SAWC) Spring | Wound Healing Society (WHS) is the leading meeting dedicated to the management, treatment, and prevention of wounds. This year, the event was co-hosted with The Wound Care Collaborative Community (WCCC) Driving Innovation Summit to bring together the latest education on wound care prevention and management, scientific excellence, and the development of innovative wound-healing therapies to improve patient outcomes.

2025-03-31Barcelona, Spain

Oneness Biotech Participated in European Wound Management Association 2025 Annual Conference

The European Wound Management Association (EWMA) Annual Conference is one of the most prominent international events in the field of wound care, bringing together clinicians, researchers, and industry professionals to share the latest developments in wound management, clinical practices, and innovation.

1 2

News & Insights

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia.

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia.

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by EDA Egypt.

Bonvadis® topical cream received medical device import license for all indications in wounds for India.

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Health Canada.

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Argentina National Administration of Drugs, Foods, and Medical Devices (ANMAT).

Events

Oneness Biotech Highlights Global Strategy at J.P. Morgan Healthcare Conference

Oneness Biotech to participate in the 16th International Diabetic Foot Course 2025

Expert Talk Recap: Dr. Brock Liden, DPM on Transforming Outcomes in VLU & Chronic Wounds

Expert Talk Recap: Dr. Chia-Ding Shih, DPM, MPH on Achieving Complete Healing in Challenging Infected DFUs

Expert Talks – Meet with Chia-Ding Shih, DPM, on September 5th at 1:00 PM at SAWC Fall 2025

Expert Talk Recap: Dr. Daniel L. Kapp, MD on Fast Healing Solution for Post-Surgical Wounds

Oneness Biotech to Exhibit at the Symposium on Advanced Wound Care (SAWC) Fall 2025

Oneness Biotech Participated in SAWC | WHS Spring meeting on April 30-May 4, 2025

Oneness Biotech Participated in European Wound Management Association 2025 Annual Conference

Media Gallery

Bonvadis Topical Cream (US Rx) Secondary Packaging

Bonvadis Topical Cream (US Rx) Primary Packaging

Bonvadis Topical Cream (US Rx) Primary and Secondary Packaging